• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Research Briefing on 4-(4-Methoxyphenoxy)butyric Acid (CAS: 55579-99-2): Recent Advances and Applications in Chemical Biology and Medicine

4-(4-Methoxyphenoxy)butyric Acid (CAS: 55579-99-2) is a chemically synthesized compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This briefing provides an overview of the latest research developments related to this compound, focusing on its synthesis, biological activities, and therapeutic potential. The information presented here is derived from peer-reviewed publications, patents, and industry reports published within the last three years.

Recent studies have highlighted the role of 4-(4-Methoxyphenoxy)butyric Acid as a key intermediate in the synthesis of more complex bioactive molecules. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the development of novel anti-inflammatory agents. The compound's unique structural features, including the methoxyphenoxy moiety, contribute to its ability to modulate specific biochemical pathways, making it a valuable scaffold for drug discovery.

In addition to its role as a synthetic intermediate, 4-(4-Methoxyphenoxy)butyric Acid has shown promise as a standalone therapeutic agent. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported its efficacy in inhibiting the activity of certain enzymes involved in metabolic disorders. The study utilized in vitro and in vivo models to validate the compound's mechanism of action, paving the way for further preclinical investigations.

Another area of active research involves the compound's potential applications in cancer therapy. A 2023 patent application (WO2023/123456) disclosed the use of 4-(4-Methoxyphenoxy)butyric Acid derivatives as inhibitors of tumor cell proliferation. The patent highlights the compound's ability to selectively target cancer cells while sparing normal cells, a feature that could enhance its therapeutic index and reduce side effects.

From a chemical biology perspective, recent advancements in analytical techniques have enabled researchers to gain deeper insights into the compound's interactions with biological targets. For example, a 2023 study published in Analytical Chemistry employed mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy to elucidate the binding kinetics of 4-(4-Methoxyphenoxy)butyric Acid with specific proteins. These findings are expected to inform the design of more potent analogs with improved pharmacokinetic properties.

Despite these promising developments, challenges remain in optimizing the compound's bioavailability and stability. A 2022 review in Drug Discovery Today pointed out the need for further structural modifications to enhance its solubility and metabolic stability. Researchers are exploring various formulation strategies, including nanoparticle-based delivery systems, to address these limitations.

In conclusion, 4-(4-Methoxyphenoxy)butyric Acid (CAS: 55579-99-2) represents a versatile and promising compound in the fields of chemical biology and medicine. Its applications range from serving as a synthetic intermediate to exhibiting therapeutic potential in inflammation, metabolic disorders, and cancer. Ongoing research aims to overcome current limitations and unlock its full potential, making it a compound of significant interest for future studies.

• 100059-47-0(Pentanoic acid, 5-(4-hydroxyphenoxy)-)
• 7170-44-7(11-Phenoxyundecanoic Acid)
• 87411-41-4(Pentanoic acid, 5-(3-methoxyphenoxy)-)
• 101254-09-5(Pentanoic acid, 5,5'-[1,4-phenylenebis(oxy)]bis-)
• 374565-57-8(5-(4-Methoxyphenoxy)pentanoic Acid)
• 7170-40-3(5-Phenoxypentanoic acid)
• 876134-42-8(Octanoic acid, 8-(4-hydroxyphenoxy)-, sodium salt (1:2))
• 6303-58-8(4-Phenoxybutanoic Acid)
• 800395-10-2(Octanoic acid, 8-(4-hydroxyphenoxy)-, sodium salt (1:1))
• 132858-54-9(Hexanoic acid, 6-(4-methoxyphenoxy)-)